INOVIO PHARMACEUTICALS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
INOVIO PHARMACEUTICALS, INC. (INO) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-03-12
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-06-30 was 87.88K shares.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2019 was 0.00 shares.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2018 was 0.00 shares, a 100.00% decline from fiscal 2017.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 140.53K shares.
- INOVIO PHARMACEUTICALS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 0.00 shares, a 100.00% decline from fiscal 2015.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | 0.00 shares 10-K · filed 2020-03-12 | |||
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | ||
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-12 | |||
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-08 | 0.00 shares 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | 87.88K shares 10-Q · filed 2019-08-08 | 86.07K shares 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 140.53K shares 10-K · filed 2020-03-12 | |||
| 2017-09-30 | 138.66K shares 10-Q · filed 2018-11-08 | 148.60K shares 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-07 | 0.00 shares 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | 148.28K shares 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2019-03-12 | |||
| 2016-09-30 | 186.17K shares 10-Q · filed 2017-11-08 | 0.00 shares 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-08 | 0.00 shares 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | 167.12K shares 10-K · filed 2018-03-14 | |||
| 2015-09-30 | 1.93M shares 10-Q · filed 2016-11-09 | 172.48K shares 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | 182.76K shares 10-Q · filed 2016-08-08 | 178.00K shares 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | 172.34K shares 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | 280.90K shares 10-K · filed 2017-03-15 | |||
| 2014-09-30 | 209.92K shares 10-Q · filed 2015-11-09 | 310.67K shares 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | 242.36K shares 10-Q · filed 2015-08-10 | 253.52K shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 0.00 shares 10-K · filed 2016-03-14 | |||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-10 | 0.00 shares 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-11 | 0.00 shares 10-Q · filed 2014-08-11 | ||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |